REGISTERED
on 19 Jul 2022
Last Applicant/ Owned by
7144 13TH PLACE NW SUITE 2200
Washington
DC
20012
Serial Number
88809441 filed on 25th Feb 2020
Registration Number
6798303 registered on 19th Jul 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
VERIMMUNE
Pharmaceutical research and development; medical research, namely, developing immune modulators for the prevention and treatment of cancer and tumors; research and development in the field of pharmaceutical preparations for immune modulators for the prevention and treatment of cancer and tumors
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; medical research, namely, developing immune modulators for the prevention and treatment of cancer and tumors; research and development in the field of pharmaceutical preparations for immune modulators for the prevention and treatment of cancer and tumors
First Use Date in General
01st Jan 2020
First Use Date in Commerce
01st Jan 2020
Mark Details
Serial Number
No 88809441
Mark Type
No Service Mark
Attorney Docket Number
No 8003/TM
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 19th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
| 14th Jun 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 13th Jun 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 09th Jun 2022 | ASSIGNED TO EXAMINER |
| 16th May 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 13th May 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 04th May 2022 | USE AMENDMENT FILED |
| 04th May 2022 | TEAS STATEMENT OF USE RECEIVED |
| 13th Nov 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |